(Total Views: 88)
Posted On: 08/29/2025 2:24:48 PM
Post# of 25783
$SHMN The company has successfully demonstrated that ABBIE version 2, featuring an advanced dCas12a domain, can effectively modify cultured human cells, marking a critical advancement toward commercial-ready gene editing technology. https://finance.yahoo.com/news/sohm-achieves-...00066.html
(0)
(0)
